KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Xwell (XWEL) EBITDA (2016 - 2025)

Xwell's EBITDA history spans 16 years, with the latest figure at -$121000.0 for Q3 2025.

  • For Q3 2025, EBITDA rose 97.54% year-over-year to -$121000.0; the TTM value through Sep 2025 reached -$13.2 million, up 7.85%, while the annual FY2024 figure was -$16.4 million, 43.97% up from the prior year.
  • EBITDA for Q3 2025 was -$121000.0 at Xwell, up from -$1.6 million in the prior quarter.
  • Across five years, EBITDA topped out at $6.5 million in Q3 2021 and bottomed at -$14.2 million in Q4 2022.
  • The 5-year median for EBITDA is -$4.7 million (2021), against an average of -$4.3 million.
  • The largest annual shift saw EBITDA soared 198.76% in 2021 before it crashed 887.77% in 2022.
  • A 5-year view of EBITDA shows it stood at $1.8 million in 2021, then plummeted by 887.77% to -$14.2 million in 2022, then soared by 64.17% to -$5.1 million in 2023, then crashed by 38.8% to -$7.1 million in 2024, then surged by 98.29% to -$121000.0 in 2025.
  • Per Business Quant, the three most recent readings for XWEL's EBITDA are -$121000.0 (Q3 2025), -$1.6 million (Q2 2025), and -$4.4 million (Q1 2025).